Market Tracker

03/06 6:48am ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

35.30
Delayed Data
As of Mar 05
 -0.44 / -1.23%
Today’s Change
28.26
Today|||52-Week Range
45.45
-13.63%
Year-to-Date

Today’s Trading

Previous close35.74
Today’s open36.00
Day’s range35.18 - 36.83
Volume471,923
Average volume (3 months)741,733
Market cap$1.5B
Dividend yield--
Data as of 03/05/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-170.80%
Earnings growth (next 5 years)+15.50%
Revenue growth (last year)+19.34%
P/E ratio85.0
Price/Sales4.19
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...+0.47+3.52%
GWPHGW Pharmaceuticals P...+1.37+1.68%
CMRXChimerix Inc+0.05+0.12%
NLNKNewLink Genetics Cor...-0.60-1.21%
Data as of 03/05/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts